Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lasse Maywald

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Oncology (Toronto, Ont.)|October 28, 2025
Readability of Chatbot Responses in Prostate Cancer and Urological Care: Objective Metrics Versus Patient PerceptionsLasse Maywald, Lisa Nguyen, Jana Theres Winterstein, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2025
Enhancing clinicians' trust in large language models via transparent source attribution: A randomized controlled evaluation in uro-oncologyNicolas Carl, Martin Joachim Hetz, Christoph Wies, et al.
Journal of Visualized Experiments : Jove|June 29, 2026
Standardized Ileal Bladder Augmentation For Enterocystoplasty In Rats via Midline LaparotomyAlexander Studier-Fischer, Lasse Maywald, Paula Grützner, et al.
Clinical and Translational Medicine|March 7, 2023
Novel insights in the pathomechanism of Brugada syndrome and fever-related type 1 ECG changes in a preclinical study using human-induced pluripotent stem cell-derived cardiomyocytesYingrui Li, Hendrik Dinkel, Dalia Pakalniskyte, et al.
International Journal of Molecular Sciences|August 12, 2022
A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem CellsRujia Zhong, Theresa Schimanski, Feng Zhang, et al.
Clinical and Translational Medicine|December 26, 2021
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screeningIbrahim El-Battrawy, Huan Lan, Lukas Cyganek, et al.
Stem Cell Research & Therapy|December 2, 2025
Phenotypes in Brugada syndrome with different genotypes triggered by fever or inflammation using gene-edited iPSCsYingrui Li, Lena Rose, Timo Prädel, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|October 28, 2025
Readability of Chatbot Responses in Prostate Cancer and Urological Care: Objective Metrics Versus Patient PerceptionsLasse Maywald, Lisa Nguyen, Jana Theres Winterstein, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2025
Enhancing clinicians' trust in large language models via transparent source attribution: A randomized controlled evaluation in uro-oncologyNicolas Carl, Martin Joachim Hetz, Christoph Wies, et al.
Journal of Visualized Experiments : Jove|June 29, 2026
Standardized Ileal Bladder Augmentation For Enterocystoplasty In Rats via Midline LaparotomyAlexander Studier-Fischer, Lasse Maywald, Paula Grützner, et al.
Clinical and Translational Medicine|March 7, 2023
Novel insights in the pathomechanism of Brugada syndrome and fever-related type 1 ECG changes in a preclinical study using human-induced pluripotent stem cell-derived cardiomyocytesYingrui Li, Hendrik Dinkel, Dalia Pakalniskyte, et al.
International Journal of Molecular Sciences|August 12, 2022
A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem CellsRujia Zhong, Theresa Schimanski, Feng Zhang, et al.
Clinical and Translational Medicine|December 26, 2021
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screeningIbrahim El-Battrawy, Huan Lan, Lukas Cyganek, et al.
Stem Cell Research & Therapy|December 2, 2025
Phenotypes in Brugada syndrome with different genotypes triggered by fever or inflammation using gene-edited iPSCsYingrui Li, Lena Rose, Timo Prädel, et al.
Pageof 1